EVALUATING GLYCEMIC CONTROL EFFICACY AND SAFETY OF THE ORAL SMALL MOLECULE GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST DANUGLIPRON IN TYPE 2 DIABETES PATIENTS: A SYSTEMIC REVIEW AND META-ANALYSIS